FDA supports critical research to advance drug and biologics development
Under this programme, the FDA engages with industry early in their process of developing new technology, and helps resolve any…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lindström India launches India’s first cleanroom unit in Pune
The staff in the unit has received special training from experts in Finland and operates under classified cleanroom environment
Ajanta Pharma Q1 net up 12 % at ₹ 106 cr
Consolidated income from operations stood at ₹ 510.99 crore for the reported quarter
Zydus Cadila gets US FDA nod for anti-bacterial drug
The medication is used to treat respiratory infections, skin infections, ear infections and sexually transmitted diseases
Aurobindo Pharma receives USFDA approval for Bivalirudin injection
The estimated market size of Bivalirudin injection is US$ 101 million for the twelve months ending May 2018 according to IQVIA
Lupin’s Mandideep facility gets approval from EDQM
The unit was inspected by EDQM during March 2018
Twin USFDA approvals for Morepen Labs’ Bulk Drugs (API) facilities
Baddi facility gets US FDA nod for bulk drug 'Atorvastatin' and Masulkhana facility for 'Montelukast'
Wockhardt sets up its first manufacturing and R&D unit in Middle East
Wockhardt inaugurates a ‘state-of-the-art’ manufacturing facility for the production and packaging of sterile dry powder injection…
Zydus Cadila gets US FDA nod to market Vardenafil tablets
The product will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad
Gujarat FDCA, bioMerieux India conducts workshop on pharmaceutical microbiology
65 drugs inspector of FDCA participated in this knowledge sharing workshop
International Women Health and Breast Cancer Conference, coming soon
The event will focus on how the health of women will overall improve the health of the world
Jubilant Life Sciences pharma revenue is at INR 1,181 crore,up by 46%
The international revenues are at INR 1,507 crore, around 72 per cent of sales
Dr Reddy’s saw a year-on-year growth of 16% in the PSAI sector
Revenues from India were at INR 6.1 billion and year-on-year growth was 30 per cent
Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US
It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older
Biocon Q1FY19 revenue INR 1,193 cr, up 21%
EBITDA up 25 per cent at INR 307 cr; Net Profit up 47per cent at INR 120 cr
GNH India firefights industrial poisoning
The company is a catalyst that ensures that life-saving medicines reach the appropriate places within a short period of time
Sanofi Pasteur launches FluQuadri, India’s first four-strain influenza vaccine
Quadrivalent influenza vaccines are the latest innovative prevention tools to provide broader protection against influenza
Patent Gurukul announces new PG certificate course in patent law & practice
The three-month course intends to train students with claims drafting, filing of patent application and patent prosecution
Dr Reddy’s Laboratories announces launch of Hervycta (trastuzumab biosimilar) in India
Hervycta is indicated for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer
Glenmark announces study supporting biosimilarity criteria for GBR 310 compared to the reference…
Glenmark is seeking use of GBR 310 for the same indications as the reference biologic for the treatment of allergic asthma and…